Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: Long-Term Safety Study of KW-6002 (Istradefylline) in Parkinson's Disease Patients [Phase 3]
The Phase 3 long-term safety study of KW-6002 (Istradefylline) in Parkinson's disease has completed. The update confirms completion status o…
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa [Phase 2]
This document provides an update on a completed Phase 2b trial of istradefylline (KW-6002) as add-on therapy to levodopa for Parkinson's dis…
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms [Phase 4]
Phase 4 study evaluating whether DaTSCAN imaging changes clinical management in patients with clinically uncertain parkinsonism or similar s…
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease [Phase 2]
A Phase 2 trial of istradefylline (KW-6002) for Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: Study of KW-6002 (Istradefylline) for the Treatment of Parkinson's Disease in Patients Taking Levodopa [Phase 3]
Phase 3 study of KW-6002 (istradefylline) as add-on therapy to levodopa for Parkinson's disease has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-08-24Clinical Trial Update: Pramipexole Conversion to Ropinirole Controlled Release (CR) [Phase 3]
Phase 3 trial evaluating switching from pramipexole to ropinirole controlled-release in Parkinson disease; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-17Clinical Trial Update: To Assess the Effect of Administration of 2 Formulation of AZD3241 on Blood Concentration in Healthy Volunteers [Phase 1]
Phase 1 pharmacokinetic study comparing two formulations of AZD3241 on blood concentrations in healthy volunteers. The trial status is compl…
-
CLINICAL_TRIALS trial_result · 2012-08-14Clinical Trial Update: Double-Blind, Multicenter, Sham Surgery Controlled Study of CERE-120 in Subjects With Idiopathic Parkinson's Disease [Phase 2]
A Phase 2 double-blind, multicenter, sham-surgery controlled trial of CERE-120 in idiopathic Parkinson's disease has completed with results …
-
FDA approval · 2012-08-13FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for bromocriptine mesylate (ANDA 078899) submitted by Zydus Pharmaceuticals USA Inc., granting regul…
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: GM1 Ganglioside Effects on Parkinson's Disease [Phase 2]
This document reports the completion of a Phase 2 trial evaluating GM1 ganglioside for Parkinson disease, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: Effect of Intravenous Amantadine on Gait Freezing in Parkinson's Disease [Phase 4]
A Phase 4 clinical trial evaluating intravenous amantadine for gait freezing in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-08Clinical Trial Update: Combined STN/SNr-DBS for the Treatment of Refractory Gait Disorders in Parkinson's Disease [Phase 2]
Phase 2 trial evaluating combined subthalamic nucleus and substantia nigra pars reticulata deep brain stimulation for refractory gait disord…
-
CLINICAL_TRIALS trial_result · 2012-08-07Clinical Trial Update: A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa [Phase 3]
Phase III randomized trial of ropinirole prolonged-release as adjunctive therapy in Parkinson's disease patients not optimally controlled on…
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: Phosphorylation of ERK1/2 in Patients With Parkinson's Disease
A completed clinical trial evaluating phosphorylation of ERK1/2 in patients with Parkinson disease.
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Pharmacokinetic Properties of Rasagiline (Lu 00-773) in Healthy Young Chinese Men and Women [Phase 1]
Phase 1 pharmacokinetic study of rasagiline was conducted in healthy young Chinese men and women to characterize absorption, distribution, m…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Domperidone as a Treatment for Dopamine Agonist-induced Peripheral Edema in Patients With Parkinson's Disease [Phase 2]
A Phase 2 clinical trial investigating domperidone to treat dopamine agonist-induced peripheral edema in Parkinson's disease was terminated.
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease [Phase 2]
Phase 2 study of ADX48621 for Levodopa-induced dyskinesia in Parkinson's disease has completed. Sponsor: Addex Pharma S.A.
-
CLINICAL_TRIALS trial_result · 2012-07-10Clinical Trial Update: Study on the Effect of External Magnetic Stimulation on Patients With Parkinson's Disease
This update reports that a clinical trial evaluating external magnetic stimulation in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-10Clinical Trial Update: A Clinical Trial to Find Out V81444's Side Effects and Blood Levels in Healthy Men [Phase 1]
Phase 1 trial assessing V81444's side effects and blood levels in healthy male volunteers, sponsored by Vernalis (R&D) Ltd. Parkinson's dise…
-
CLINICAL_TRIALS trial_result · 2012-07-09Clinical Trial Update: D-serine Adjuvant Treatment for Parkinson's Disease [Phase 4]
Phase 4 trial update evaluating D-serine as an adjuvant treatment for Parkinson's disease; the study status is completed.
-
EMA guidance · 2012-07-06European Medicines Agency finalises update to Parkinson's disease guideline
EMA finalizes an update to its guideline on Parkinson's disease to reflect current scientific understanding and regulatory expectations.
-
CLINICAL_TRIALS research · 2012-07-04Clinical Trial Update: Quantification of Cerebral Cholinergic Function in Parkinson´s Disease by Means of Nuclear Medicine Methods
This clinical trial update reports on quantifying cerebral cholinergic function in Parkinson's disease using nuclear medicine imaging; the s…
-
CLINICAL_TRIALS trial_result · 2012-06-29Clinical Trial Update: Capturing Parkinson's Disease Medication Side Effects During Daily Activities
A completed clinical trial update from Great Lakes NeuroTechnologies focused on capturing Parkinson's disease medication side effects during…
-
CLINICAL_TRIALS trial_result · 2012-06-22Clinical Trial Update: A Study Comparing the Safety and Tolerability of Two Doses of Fipamezole in Adult Patients With Parkinson's Disease
A completed study comparing the safety and tolerability of two doses of fipamezole in adults with Parkinson's disease.
-
CLINICAL_TRIALS research · 2012-06-22Clinical Trial Update: Evaluation of a Diet in Patients With Senile Dementia [NA]
Clinical trial update on evaluating a dietary intervention in patients with senile dementia, including Alzheimer's disease and Parkinson's d…